XML 25 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Note 2 - Acquisition
9 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Business Combination Disclosure [Text Block]

(2) 

ACQUISITION

 

On January 4, 2021, we acquired substantially all assets and assumed certain liabilities of PatientWisdom, Inc., a company with a health engagement solution that will further our purpose of operationalizing human understanding through tangible and actionable insights. $3.0 million of the total $5.0 million all-cash consideration was paid at closing. We are required to pay the remaining $2.0 million no later than February 1, 2022, subject to offset for indemnification claims as provided in the purchase agreement. The closing payment was funded, and we expect to fund the deferred portion of the purchase price, with cash on hand. The acquisition was accounted for as a business combination, using the acquisition method of accounting, which requires, among other things, certain assets acquired and liabilities assumed to be recognized at their fair values as of the acquisition date.

 

The following table summarizes the preliminary fair value of assets acquired and liabilities assumed at the acquisition date.

 

Amount of Identified Assets Acquired and Liabilities Assumed

 
   

($ in thousands)

 

Current Assets

  $ 184  

Property and equipment

    10  

Customer related

    100  

Technology

    600  

Goodwill

    4,340  

Total assets acquired

  $ 5,234  

Current liabilities

    284  

Net assets acquired

  $ 4,950  

 

The identifiable intangible assets are being amortized over their estimated useful lives of 5 years. The goodwill and identifiable intangible assets are deductible for tax purposes. Goodwill related to the acquisition was primarily attributable to anticipated synergies and other intangibles that do not qualify for separate recognition.

 

The financial results associated with the PatientWisdom assets we acquired and liabilities we assumed are included in our consolidated financial statements from the date of acquisition, although the amounts are insignificant for 2021. Pro-forma information has not been presented because the amounts for 2021 are insignificant. Acquisition-related costs of $119,000 are included in selling, general and administrative expenses for the nine-month periods ended September 30, 2021.